Warning! GuruFocus detected
6 Severe warning signs
with OPK.
Try a 7-Day Free Trial
to check it out.
What is a stock summary page? Click here for an overview.
Business Description
OPKO Health Inc
NAICS : 339116
SIC : 2835
ISIN : US68375N1037
Compare
Compare
Traded in other countries / regions
OPK.USAOPK.Israel0KCS.UKXCY.GermanyOPK.Mexico Index Membership
Russell 2000Russell 3000 IPO Date
1995-11-02Description
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.86 | |||||
| Equity-to-Asset | 0.62 | |||||
| Debt-to-Equity | 0.37 | |||||
| Debt-to-EBITDA | 3.73 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | 0.15 | |||||
| Beneish M-Score | -2.71 | |||||
| WACC vs ROIC | ||||||
Growth Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -27.9 | |||||
| 3-Year EBITDA Growth Rate | 14.8 | |||||
| 3-Year EPS without NRI Growth Rate | -29 | |||||
| 3-Year Book Growth Rate | -6.3 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 5.31 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 30.12 | |||||
| 9-Day RSI | 43.87 | |||||
| 14-Day RSI | 49.72 | |||||
| 3-1 Month Momentum % | 4.4 | |||||
| 6-1 Month Momentum % | 5.73 | |||||
| 12-1 Month Momentum % | 80.57 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.43 | |||||
| Quick Ratio | 3.13 | |||||
| Cash Ratio | 2.24 | |||||
| Days Inventory | 44.49 | |||||
| Days Sales Outstanding | 57.8 | |||||
| Days Payable | 49.13 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | 0.5 | |||||
| Shareholder Yield % | -2.63 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 30.64 | |||||
| Operating Margin % | -38.36 | |||||
| Net Margin % | -7.46 | |||||
| FCF Margin % | -29.24 | |||||
| ROE % | -3.91 | |||||
| ROA % | -2.55 | |||||
| ROIC % | -80.44 | |||||
| 3-Year ROIIC % | 350.28 | |||||
| ROC (Joel Greenblatt) % | 18.35 | |||||
| ROCE % | 1.97 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Price-to-Owner-Earnings | 17.23 | |||||
| PS Ratio | 1.83 | |||||
| PB Ratio | 0.86 | |||||
| Price-to-Tangible-Book | 43.5 | |||||
| EV-to-EBIT | 33.09 | |||||
| EV-to-EBITDA | 9.07 | |||||
| EV-to-Revenue | 1.72 | |||||
| EV-to-Forward-Revenue | 1.86 | |||||
| EV-to-FCF | -5.89 | |||||
| Price-to-GF-Value | 1.55 | |||||
| Price-to-Projected-FCF | 5.8 | |||||
| Price-to-Median-PS-Value | 1.07 | |||||
| Earnings Yield (Greenblatt) % | 3.02 | |||||
| FCF Yield % | -17.84 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:OPK
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
OPKO Health Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 713.142 | ||
| EPS (TTM) ($) | -0.09 | ||
| Beta | 1.47 | ||
| 3-Year Sharpe Ratio | -0.14 | ||
| 3-Year Sortino Ratio | -0.21 | ||
| Volatility % | 36.2 | ||
| 14-Day RSI | 49.72 | ||
| 14-Day ATR ($) | 0.089912 | ||
| 20-Day SMA ($) | 1.7505 | ||
| 12-1 Month Momentum % | 80.57 | ||
| 52-Week Range ($) | 0.8601 - 2.035 | ||
| Shares Outstanding (Mil) | 671.55 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
OPKO Health Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
OPKO Health Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
OPKO Health Inc Frequently Asked Questions
What is OPKO Health Inc(OPK)'s stock price today?
The current price of OPK is $1.74. The 52 week high of OPK is $2.04 and 52 week low is $0.86.
When is next earnings date of OPKO Health Inc(OPK)?
The next earnings date of OPKO Health Inc(OPK) is 2025-05-07 Est..
Does OPKO Health Inc(OPK) pay dividends? If so, how much?
OPKO Health Inc(OPK) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers